scholarly journals Effect of Systemic Subnormal Deuterium Level on Metabolic Syndrome Related and other Blood Parameters in Humans: A Preliminary Study

Author(s):  
Gábor Somlyai ◽  
Ildikó Somlyai ◽  
István Fórizs ◽  
György Czuppon ◽  
András Papp ◽  
...  
Author(s):  
Gábor Somlyai ◽  
Ildikó Somlyai ◽  
István Fórizs ◽  
György Czuppon ◽  
András Papp ◽  
...  

2007 ◽  
Vol 36 (3) ◽  
pp. 311-317 ◽  
Author(s):  
Mi-Kyeong Choi ◽  
Ye-Sook Jun ◽  
Yun-Jung Bae ◽  
Chung-Ja Sung

2020 ◽  
pp. postgradmedj-2020-138667
Author(s):  
Seyma Kalkuz ◽  
Ayça Demircan

BackgroundIt has been reported that Mediterranean diet (MD) may improve quality of life and may reduce the risk of chronic diseases such as metabolic syndrome, type 2 diabetes, cardiovascular diseases (CVD), some neurodegenerative diseases and cancer. Therefore, this study aimed to determine adults’ adherence to the MD and evaluate the effect of the adherence to the MD on anthropometric measurements, specific biochemical parameters and quality of life.MethodsA total of 142 volunteer adults were included. Food frequency questionnaire, MD adherence with 14-item scale, quality of life, anthropometric measurements via bioelectrical impedance analysis and certain blood parameters were evaluated.ResultsOut of 14 points, the mean MD adherence score of the participants was 6.89. The mean fat mass was significantly higher in those with low MD adherence (p=0.024). The results of other anthropometric measurements (except height) were higher in those with low MD adherence, though results were non-significant. The participants with high adherence to the MD had lower levels of fasting blood glucose (FBG) (p=0.041), insulin (p=0.019) and triglyceride (TG) (p=0.012) compared with those with lower adherence. No significant relationship was found between the MD and quality of life and other blood parameters.ConclusionAccording to our study, MD adherence was associated with decreased fat mass, FBG, insulin and TG levels which suggests that the MD may be useful in the treatment of some chronic diseases such as obesity, diabetes, metabolic syndrome and CVD. However, more clinical trials may be performed to determine the relationship between MD and chronic diseases.


2019 ◽  
Vol 96 (1140) ◽  
pp. 600-605
Author(s):  
Tuba Tekin ◽  
Betül Çiçek ◽  
Nurefşan Konyalıgil ◽  
İnayet Güntürk ◽  
Cevat Yazıcı ◽  
...  

BackgroundThis case–control study was conducted to investigate the relationship between serum nesfatin-1 levels and nutritional status and blood parameters in patients diagnosed with metabolic syndrome.MethodsThirty patients (case) diagnosed with metabolic syndrome according to National Cholesterol Education Program-Adult Treatment Panel III criteria were included. Thirty healthy subjects (control) matched with patients with metabolic syndrome in terms of age, gender and body mass index were included. Three-day food consumption records were obtained. Anthropometric indices were measured and body composition was determined by bioelectrical impedance method. Biochemical parameters and serum nesfatin-1 levels were measured after 8 hours of fasting.ResultsSerum nesfatin-1 levels were 0.245±0.272 ng/mL in the case group and 0.528±0.987 ng/mL in the control group (p>0.05). There was a positive significant correlation between serum nesfatin-1 levels and body weight, waist and hip circumferences in the case group (p<0.05). Each unit increase in hip circumference measurement affects the levels of nesfatin by 0.014 times. In the control group, there was a positive significant correlation between body weight and serum nesfatin-1 levels (p<0.05). A significant correlation was detected between HbA1c and serum nesfatin-1 levels in the case group (p<0.05). A significant relationship was detected between dietary fibre intake and the serum nesfatin-1 levels in the case group (p<0.05).ConclusionsAnthropometric indices and blood parameters were correlated with serum nesfatin-1 levels in patients with metabolic syndrome. More clinical trials may be performed to establish the relationship between serum nesfatin-1 levels and nutritional status.


Author(s):  
Dhananjay Yadav ◽  
Shweta Tarar ◽  
Neha Ghosh ◽  
R P Tiwari ◽  
PS Bisen ◽  
...  

2015 ◽  
Vol 7 (2) ◽  
pp. 53 ◽  
Author(s):  
EU Nwose ◽  
PT Bwititi ◽  
VM Oguoma ◽  
RS Richards

2017 ◽  
Vol 15 (9) ◽  
pp. 465-473 ◽  
Author(s):  
Tatiana Toro-Ramos ◽  
Dong-Hwa Lee ◽  
Youngin Kim ◽  
Andreas Michaelides ◽  
Tae Jung Oh ◽  
...  

2002 ◽  
Vol 12 (3) ◽  
pp. 310-317 ◽  
Author(s):  
Laura Lewis Frank ◽  
Janine T. Baer ◽  
Charles P. Lambert ◽  
Mark L. Anderson

The effect of fungal carbohydrases (Carbogen™ [C]) consumed with a meal replacement bar (MBR) on glucose metabolism and exercise performance was determined in 5 male competitive cyclists. After a 12-hour fast, subjects performed two 60-min cycling bouts at 80% V̇O2max followed by a time-to-exhaustion (TE) ride at 100% V̇O2max. One hour prior to each cycling bout, subjects ingested a MRB + 160-mg C or 160-mg CaCO3 placebo (PL) in a double-blind, counterbalanced fashion. Blood was drawn for determination of glucose, insulin, and lactate at: fasting, 1 hour post-feeding, minutes 30 and 60 of exercise, and after TE. Two-way ANOVA revealed a significant (p < .05) treatment and time effect for glucose, with C being higher than PL. Interaction effects were ob-· served for insulin and lactate. An increase in TE (min) at 100% V̇O2max was observed in the C versus PL trial (6.3 ± 3.4 vs. 4.4 ± 2.9, p < .001). A MRB+C may benefit cyclists due to increased BG and improved exercise performance.


Sign in / Sign up

Export Citation Format

Share Document